Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today

Benzinga05:15

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio With Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

Benzinga03:47

BMO Capital Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $520

Futu NewsJan 14 21:31 · Ratings

Bernstein Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating, Maintains Target Price $441

Futu NewsJan 14 21:31 · Ratings

Barclays Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating, Maintains Target Price $418

Futu NewsJan 14 21:31 · Ratings

A Quick Look at Today's Ratings for Vertex Pharmaceuticals(VRTX.US), With a Forecast Between $418 to $575

Futu NewsJan 14 21:00 · Ratings